+31.9%
CVS vs CVE
+317.2%
-285.3%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CVE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.5% | -1.3% | +0.8% | -0.4% |
| 7D | +4.0% | +2.5% | +1.5% | +3.7% |
| 30D | -2.4% | +16.7% | -19.1% | -3.8% |
| 3M | +2.7% | +9.3% | -6.6% | +1.6% |
| 6M | +21.9% | +43.6% | -21.7% | +17.4% |
| YTD | +24.7% | +93.6% | -68.8% | +16.5% |
| 1Y | +35.4% | +98.8% | -63.3% | +25.8% |
| 3Y | +65.2% | +73.6% | -8.4% | +53.6% |
| All | +31.9% | +317.2% | -285.3% | +6.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CVE.
Daily Out/Under-Performance
Portfolio return minus CVE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CVE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling